The NADP can support you in finding project partners for projects aimed at the development of new antibiotics and alternative therapies (prevention and care) for human and animal health. You can contact NADP via [email protected] with your questions about matchmaking and opportunities for your own project.
Support researchers and SMEs to bring novel antibiotics and alternatives a step closer to the clinic.
Continuous application - check collection dates
Horizon2020 Work Programmes
Horizon 2020 is the financial instrument of the European Commission that aims to drive economic growth and create jobs. Within Horizon 2020, research and innovation are coupled with an emphasis on excellent science, industrial leadership and tackling societal challenges.
Health, demographic change and wellbeing: first stage 23 January 2019, second stage 4 September 2019
Food security, sustainable agriculture and forestry, marine, maritime and inland water research and the bioeconomy: first stage 13 February 2019, second stage 11 September 2019
Partnering with AMR Centre (U.K.)
AMR Centre’s accelerates the development of new antimicrobial drugs and diagnostics. As such the AMR Centre works globally with companies and research institutions to support the development of their products from lead optimization through to Phase 2A. The AMR Centre aims to progress circa 5 new projects each year.
Novartis Venture Fund
The Novartis Venture Fund makes equity investments in life science companies focussing on the development of novel therapeutics and platforms. Investments by the Novartis Venture Fund are made as equity participation typically as the lead or co-lead investor in a syndicate with a board seat. The Novartis Venture Fund has a relatively high amount of investments in the domain of infectious diseases.